AVP and depressive symptom measurement: Another study, conducted on rats and mice, demonstrated that the behavioral phenotype has been found to be significantly correlated with the expression of the neuropeptide arginine vasopressin (AVP) at the level of the hypothalamic paraventricular nucleus and contribute to hyper-anxiety and depression-like behavior and single-nucleotide polymorphisms (SNPs) in the regulation structures of the AVP gene represent the basis of the phenotypic phenomena [3].